0001192482-20-000046.txt : 20200122 0001192482-20-000046.hdr.sgml : 20200122 20200122162903 ACCESSION NUMBER: 0001192482-20-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200121 FILED AS OF DATE: 20200122 DATE AS OF CHANGE: 20200122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heffernan Michael Thomas CENTRAL INDEX KEY: 0001448914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 20539212 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC. STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-01-21 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001448914 Heffernan Michael Thomas C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 1 0 0 0 Common Stock 2020-01-21 4 M 0 275463 5.73 A 402086 D Common Stock 2020-01-21 4 S 0 262587 21.84 D 139499 D Common Stock 2020-01-21 4 S 0 32700 22.69 D 106799 D Common Stock 2020-01-21 4 F 0 787 21.56 D 106012 D Stock Option (Right to Purchase) 5.73 2020-01-21 4 M 0 275463 0 D 2025-03-30 Common Stock 275463 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2019. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.42 to $22.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.42 to $23.30, inclusive. Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. All of the 275,463 option shares are exercisable. /s/ Paul Brannelly as Attorney-In-Fact For Michael T. Heffernan 2020-01-22